investing-statsSEC Form 4 insider transactions

AVTX · Avalo Therapeutics, Inc.

← all insiders

Pharmaceutical Preparations · Listed on Nasdaq

Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON

Open-market trades10
Distinct insiders3
Bought$0
Sold$1.69M
Net flow$-1.69M

Recent filings

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Recent Form 4 filings for AVTX
FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade).InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S).SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.Link to SEC filing
2026-09-01Doyle MittieOfficer (Chief Medical Officer)M sell10b5-1679 679 Common Stock113,734filing
2026-09-01Doyle MittieOfficer (Chief Medical Officer)S sell10b5-16790$20.00$13.6K51,776−1%−<0.01% (now 0.10%)filing
2026-09-01Doyle MittieOfficer (Chief Medical Officer)M buy10b5-16790$8.04$5.5K52,455+1%+<0.01% (now 0.10%)filing
2026-08-19Doyle MittieOfficer (Chief Medical Officer)M sell10b5-11,000 1,000 Common Stock123,750filing
2026-08-19Doyle MittieOfficer (Chief Medical Officer)S sell10b5-11,0000$20.00$20.0K51,776−2%−<0.01% (now 0.10%)filing
2026-08-19Doyle MittieOfficer (Chief Medical Officer)M buy10b5-11,0000$12.65$12.7K52,776+2%+<0.01% (now 0.10%)filing
2026-08-19Sullivan Christopher RyanOfficer (Chief Financial Officer)M sell10b5-131,031 31,031 Common Stock96,242filing
2026-08-19Sullivan Christopher RyanOfficer (Chief Financial Officer)M sell10b5-12,876 2,876 Common Stock127,273filing
2026-08-19Sullivan Christopher RyanOfficer (Chief Financial Officer)M sell10b5-137,945 37,945 Common Stock130,149filing
2026-08-19Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-131,0310$20.05$622.3K39,900−44%−0.06% (now 0.07%)filing
2026-08-19Sullivan Christopher RyanOfficer (Chief Financial Officer)M buy10b5-131,0310$9.88$306.6K70,931+78%+0.06% (now 0.13%)filing
2026-08-19Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-13,7490$19.94$74.8K39,900−9%−<0.01% (now 0.07%)filing
2026-08-19Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-137,9450$19.85$753.3K43,649−47%−0.07% (now 0.08%)filing
2026-08-19Sullivan Christopher RyanOfficer (Chief Financial Officer)M buy10b5-12,8760$9.88$28.4K81,594+4%+<0.01% (now 0.15%)filing
2026-08-19Sullivan Christopher RyanOfficer (Chief Financial Officer)M buy10b5-137,9450$9.88$374.9K78,718+93%+0.07% (now 0.15%)filing
2026-08-12Riley JenniferOfficer (Chief Strategy Officer)S sell2,6550$19.59$52.0K37,041−7%−<0.01% (now 0.07%)filing
2026-08-12Doyle MittieOfficer (Chief Medical Officer)M sell10b5-1679 679 Common Stock114,413filing
2026-08-12Doyle MittieOfficer (Chief Medical Officer)S sell10b5-16790$20.00$13.6K51,776−1%−<0.01% (now 0.10%)filing
2026-08-12Doyle MittieOfficer (Chief Medical Officer)M buy10b5-16790$8.04$5.5K52,455+1%+<0.01% (now 0.10%)filing
2026-07-29Doyle MittieOfficer (Chief Medical Officer)M sell10b5-11,000 1,000 Common Stock124,750filing
2026-07-29Doyle MittieOfficer (Chief Medical Officer)S sell10b5-11,0000$20.00$20.0K51,776−2%−<0.01% (now 0.10%)filing
2026-07-29Doyle MittieOfficer (Chief Medical Officer)M buy10b5-11,0000$12.65$12.7K52,776+2%+<0.01% (now 0.10%)filing
2026-07-02Philip Ron MDirectorA buy69 69 Common Stock$15.04$1.0K69filing
2026-07-02Doyle MittieOfficer (Chief Medical Officer)M sell10b5-11,779 1,779 Common Stock115,092filing
2026-07-02Doyle MittieOfficer (Chief Medical Officer)M sell10b5-12,875 2,875 Common Stock125,750filing
2026-07-02Doyle MittieOfficer (Chief Medical Officer)S sell10b5-14,6540$20.00$93.1K51,776−8%−<0.01% (now 0.10%)filing
2026-07-02Doyle MittieOfficer (Chief Medical Officer)M buy10b5-11,7790$8.04$14.3K56,430+3%+<0.01% (now 0.11%)filing
2026-07-02Doyle MittieOfficer (Chief Medical Officer)M buy10b5-12,8750$12.65$36.4K54,651+6%+<0.01% (now 0.10%)filing
2026-07-02Jain RitaDirectorA buy1,080 1,080 Common Stock$15.04$16.2K1,080filing
2026-07-02Lind Kevin RobertDirectorA buy1,105 1,105 Common Stock$15.04$16.6K1,105filing
2026-06-25Philip Ron MDirectorA buy40,200 40,200 Common Stock40,200filing
2026-06-25Doyle MittieOfficer (Chief Medical Officer)M sell10b5-11,450 1,450 Common Stock116,871filing
2026-06-25Doyle MittieOfficer (Chief Medical Officer)S sell10b5-11,4500$18.00$26.1K51,776−3%−<0.01% (now 0.10%)filing
2026-06-25Doyle MittieOfficer (Chief Medical Officer)M buy10b5-11,4500$8.04$11.7K53,226+3%+<0.01% (now 0.10%)filing
2026-06-12Riley JenniferOfficer (Chief Strategy Officer)F sell5880$13.10$7.7K39,696−1%−<0.01% (now 0.07%)filing
2026-06-12Doyle MittieOfficer (Chief Medical Officer)F sell1,0840$13.10$14.2K51,776−2%−<0.01% (now 0.10%)filing
2026-06-12Sullivan Christopher RyanOfficer (Chief Financial Officer)F sell1380$13.10$1.8K40,773−0.3%−<0.01% (now 0.08%)filing
2026-06-12VARKI PAULOfficer (Chief Legal Officer)F sell1,0810$13.10$14.2K32,576−3%−<0.01% (now 0.06%)filing
2026-06-04Truex SamanthaDirectorA buy20,100 20,100 Common Stock20,100filing
2026-06-04KANTOFF AARONDirectorA buy20,100 20,100 Common Stock20,100filing
2026-06-04Jain RitaDirectorA buy20,100 20,100 Common Stock20,100filing
2026-06-04Lind Kevin RobertDirectorA buy20,100 20,100 Common Stock20,100filing
2026-06-04Heffernan Michael ThomasDirectorA buy29,500 29,500 Common Stock29,500filing
2026-06-04KAPLAN GILLADirectorA buy20,100 20,100 Common Stock20,100filing
2026-06-01Doyle MittieOfficer (Chief Medical Officer)M sell10b5-1679 679 Common Stock118,321filing
2026-06-01Doyle MittieOfficer (Chief Medical Officer)S sell10b5-16790$16.00$10.9K47,122−1%−<0.01% (now 0.09%)filing
2026-06-01Doyle MittieOfficer (Chief Medical Officer)M buy10b5-16790$8.04$5.5K47,801+1%+<0.01% (now 0.09%)filing
2026-05-26Riley JenniferOfficer (Chief Strategy Officer)A buy34,200036,85514×+0.06% (now 0.07%)filing
2026-05-26Doyle MittieOfficer (Chief Medical Officer)A buy43,500047,12213×+0.08% (now 0.09%)filing
2026-05-26Sullivan Christopher RyanOfficer (Chief Financial Officer)A buy39,900040,32395×+0.07% (now 0.08%)filing
2026-05-26VARKI PAULOfficer (Chief Legal Officer)A buy24,300027,9347.7×+0.05% (now 0.05%)filing
2026-05-26NEIL GARRY ARTHURDirector, Officer (Chief Executive Officer)A buy100,2000190,3142.1×+0.19% (now 0.35%)filing
2026-05-19Doyle MittieOfficer (Chief Medical Officer)M sell10b5-13,000 3,000 Common Stock128,625filing
2026-05-19Doyle MittieOfficer (Chief Medical Officer)S sell10b5-13,0000$18.76$56.3K3,622−45%−<0.01% (now <0.01%)filing
2026-05-19Doyle MittieOfficer (Chief Medical Officer)M buy10b5-13,0000$12.65$38.0K6,622+83%+<0.01% (now 0.01%)filing
2026-05-11Sullivan Christopher RyanOfficer (Chief Financial Officer)M sell10b5-118,606 18,606 Common Stock168,094filing
2026-05-11Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-118,6060$24.12$448.8K423−98%−0.03% (now <0.01%)filing
2026-05-11Sullivan Christopher RyanOfficer (Chief Financial Officer)M buy10b5-118,6060$9.88$183.8K19,02945×+0.03% (now 0.04%)filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)M sell10b5-128,650 28,650 Common Stock119,000filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)M sell10b5-177,905 77,905 Common Stock131,625filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)M sell10b5-1679 679 Common Stock147,650filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)M sell10b5-11,000 1,000 Common Stock209,530filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)S sell10b5-110,0580$22.88$230.1K3,622−74%−0.02% (now <0.01%)filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)S sell10b5-119,0150$22.41$426.1K13,680−58%−0.04% (now 0.03%)filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)S sell10b5-144,9440$21.20$952.7K32,695−58%−0.08% (now 0.06%)filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)S sell10b5-15,0000$19.65$98.3K77,639−6%−<0.01% (now 0.14%)filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)S sell10b5-127,5380$18.03$496.4K82,639−25%−0.05% (now 0.15%)filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)M buy10b5-128,6500$8.04$230.3K110,177+35%+0.05% (now 0.21%)filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)M buy10b5-177,9050$12.65$985.5K81,52723×+0.15% (now 0.15%)filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)S sell10b5-11,6790$16.00$26.9K3,622−32%−<0.01% (now <0.01%)filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)M buy10b5-16790$8.04$5.5K5,301+15%+<0.01% (now <0.01%)filing
2026-05-07Doyle MittieOfficer (Chief Medical Officer)M buy10b5-11,0000$12.65$12.7K4,622+28%+<0.01% (now <0.01%)filing
2026-05-07Sullivan Christopher RyanOfficer (Chief Financial Officer)M sell10b5-147,000 47,000 Common Stock116,000filing
2026-05-07Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-18,9000$22.57$200.9K423−95%−0.02% (now <0.01%)filing
2026-05-07Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-19,2190$21.37$197.0K9,323−50%−0.02% (now 0.02%)filing
2026-05-07Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-12,7000$20.76$56.1K18,542−13%−<0.01% (now 0.03%)filing
2026-05-07Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-112,3470$19.28$238.1K21,242−37%−0.02% (now 0.04%)filing
2026-05-07Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-113,8340$18.55$256.7K33,589−29%−0.03% (now 0.06%)filing
2026-05-07Sullivan Christopher RyanOfficer (Chief Financial Officer)M buy10b5-147,0000$8.04$377.9K47,423112×+0.09% (now 0.09%)filing
2026-05-07Chan MitchellDirectorS sell10b5-13,1670$22.88$72.5K3,166−50%−<0.01% (now <0.01%)filing
2026-05-07VARKI PAULOfficer (Chief Legal Officer)M sell10b5-112,563 12,563 Common Stock87,437filing
2026-05-07VARKI PAULOfficer (Chief Legal Officer)M sell10b5-162,500 62,500 Common Stock87,500filing
2026-05-07VARKI PAULOfficer (Chief Legal Officer)S sell10b5-14000$23.71$9.5K3,634−10%−<0.01% (now <0.01%)filing
2026-05-07VARKI PAULOfficer (Chief Legal Officer)S sell10b5-19,2530$22.70$210.0K4,034−70%−0.02% (now <0.01%)filing
2026-05-07VARKI PAULOfficer (Chief Legal Officer)S sell10b5-122,8390$21.22$484.5K13,287−63%−0.04% (now 0.02%)filing
2026-05-07VARKI PAULOfficer (Chief Legal Officer)S sell10b5-15,1960$19.78$102.8K36,126−13%−<0.01% (now 0.07%)filing
2026-05-07VARKI PAULOfficer (Chief Legal Officer)S sell10b5-137,3750$18.91$706.8K41,322−47%−0.07% (now 0.08%)filing
2026-05-07VARKI PAULOfficer (Chief Legal Officer)M buy10b5-112,5630$8.04$101.0K78,697+19%+0.02% (now 0.15%)filing
2026-05-07VARKI PAULOfficer (Chief Legal Officer)M buy10b5-162,5000$13.43$839.4K66,13418×+0.12% (now 0.12%)filing
2026-05-01Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-18,4570$13.23$111.9K423−95%−0.02% (now <0.01%)filing
2026-05-01Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-18,4580$13.09$110.7K8,880−49%−0.02% (now 0.02%)filing
2026-04-08Doyle MittieOfficer (Chief Medical Officer)M sell10b5-13,970 3,970 Common Stock210,530filing
2026-04-08Doyle MittieOfficer (Chief Medical Officer)S sell10b5-13,9700$18.01$71.5K3,622−52%−<0.01% (now <0.01%)filing
2026-04-08Doyle MittieOfficer (Chief Medical Officer)M buy10b5-13,9700$12.65$50.2K7,5922.1×+<0.01% (now 0.01%)filing
2026-04-03Doyle MittieOfficer (Chief Medical Officer)M sell10b5-1679 679 Common Stock148,329filing
2026-04-03Doyle MittieOfficer (Chief Medical Officer)S sell10b5-16790$16.00$10.9K3,622−16%−<0.01% (now <0.01%)filing
2026-04-03Doyle MittieOfficer (Chief Medical Officer)M buy10b5-16790$8.04$5.5K4,301+19%+<0.01% (now <0.01%)filing
2026-04-03Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-11,7800$17.57$31.3K17,338−9%−<0.01% (now 0.03%)filing
2026-04-03Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-16,2000$17.02$105.6K19,118−24%−0.01% (now 0.04%)filing
2026-04-03Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-17,4790$16.83$125.8K25,318−23%−0.01% (now 0.05%)filing
2026-04-03Sullivan Christopher RyanOfficer (Chief Financial Officer)S sell10b5-15000$15.86$7.9K32,797−2%−<0.01% (now 0.06%)filing
2026-04-01Jain RitaDirectorA buy1,339 1,339 Common Stock$12.13$16.2K1,339filing
2026-04-01Lind Kevin RobertDirectorA buy1,370 1,370 Common Stock$12.13$16.6K1,370filing
2026-03-31Truex SamanthaDirectorM sell3,166 3,166 Common Stock3,167filing
2026-03-31Truex SamanthaDirectorM buy3,16606,333+100%+<0.01% (now 0.01%)filing
2026-03-31Goldman JonathanDirectorM sell3,166 3,166 Common Stock3,167filing
2026-03-31Goldman JonathanDirectorM buy3,16603,166new+<0.01% (now <0.01%)filing
2026-03-31KANTOFF AARONDirectorM sell3,166 3,166 Common Stock3,167filing
2026-03-31KANTOFF AARONDirectorM buy3,16606,333+100%+<0.01% (now 0.01%)filing
2026-03-31Sullivan Christopher RyanOfficer (Chief Financial Officer)M sell24,200 24,200 Common Stock24,200filing
2026-03-31Sullivan Christopher RyanOfficer (Chief Financial Officer)F sell8,2410$13.89$114.5K33,297−20%−0.02% (now 0.06%)filing
2026-03-31Sullivan Christopher RyanOfficer (Chief Financial Officer)M buy24,200041,5382.4×+0.05% (now 0.08%)filing
2026-03-31Chan MitchellDirectorM sell3,166 3,166 Common Stock3,167filing
2026-03-31Chan MitchellDirectorM buy3,16606,333+100%+<0.01% (now 0.01%)filing
2026-03-31NEIL GARRY ARTHURDirector, Officer (Chief Executive Officer)M sell64,866 64,866 Common Stock64,867filing
2026-03-31NEIL GARRY ARTHURDirector, Officer (Chief Executive Officer)F sell21,8920$13.89$304.1K90,114−20%−0.04% (now 0.17%)filing
2026-03-31NEIL GARRY ARTHURDirector, Officer (Chief Executive Officer)M buy64,8660112,0062.4×+0.12% (now 0.21%)filing
2026-03-31KAPLAN GILLADirectorM sell3,166 3,166 Common Stock3,167filing
2026-03-31KAPLAN GILLADirectorM buy3,16606,333+100%+<0.01% (now 0.01%)filing

Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.